What is the recommended dosing schedule for a 1000 mg slow‑release naproxen tablet in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Naproxen 1000 mg Slow-Release Dosing

A 1000 mg slow-release naproxen tablet should be administered once daily, not every 12 hours. 1

Standard Dosing for Slow-Release Formulation

The FDA-approved dosing for slow-release (controlled-release) naproxen is once daily administration 1. This differs fundamentally from immediate-release formulations, which are typically dosed every 12 hours.

Key Dosing Parameters by Indication:

For Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis:

  • Standard dose: 250-500 mg twice daily for immediate-release formulations
  • Maximum dose can reach 1500 mg/day for limited periods (up to 6 months) when higher anti-inflammatory activity is required 1
  • The morning and evening doses do not need to be equal in size 1

For Acute Pain Management:

  • Starting dose: 500 mg, followed by 500 mg every 12 hours OR 250 mg every 6-8 hours
  • Initial daily dose should not exceed 1250 mg
  • Maintenance daily dose should not exceed 1000 mg 1

Pharmacokinetic Rationale

The once-daily dosing of 1000 mg controlled-release naproxen is supported by pharmacokinetic data showing:

  • Absorption is dependent on drug release from the tablet matrix, with mean absorption time of 9.2 hours for the 1000 mg controlled-release tablet 2
  • Once-daily administration maintains equivalent trough concentrations compared to twice-daily immediate-release formulations 2
  • Steady-state plasma concentrations are maintained within narrower limits than with twice-daily conventional naproxen 2
  • Total exposure (AUC) is comparable between once-daily controlled-release and twice-daily immediate-release formulations 3

Critical Safety Considerations

Use the lowest effective dose for the shortest duration to minimize cardiovascular and gastrointestinal risks 1.

Dose Adjustments Required For:

  • Elderly patients: Lower doses recommended due to increased unbound plasma fraction 1
  • Renal impairment: Naproxen is NOT recommended if creatinine clearance < 30 mL/min 1
  • Hepatic impairment: Consider lower doses 1

Common Pitfall to Avoid:

Do not confuse controlled-release formulations with immediate-release formulations—they are not bioequivalent and have different pharmacokinetic profiles that affect onset of action 1. A 1000 mg controlled-release tablet given once daily is appropriate, whereas the same total daily dose of immediate-release naproxen would typically be split into 500 mg twice daily.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.